These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 319318)

  • 21. The effect of halofenate or halofenate free acid on human, rat and guinea pig platelet aggregation.
    Minsker DH; Jordan PT; Kling P; MacMillan A; Hucker HB
    Thromb Haemost; 1976 Apr; 35(2):358-63. PubMed ID: 989636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
    Keller C; Wolfram G; Zöllner N
    Arzneimittelforschung; 1976; 26(12):2221-4. PubMed ID: 798591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
    Kudzma DJ; Friedberg SJ
    Diabetes; 1977 Apr; 26(4):291-5. PubMed ID: 321288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
    Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
    J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids.
    Asiedu DK; al-Shurbaji A; Rustan AC; Björkhem I; Berglund L; Berge RK
    Eur J Biochem; 1995 Feb; 227(3):715-22. PubMed ID: 7867630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
    Schapel GJ; Edwards KD
    J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
    Rees ED; Hamilton RD; Kanner IF; Wasson S; Hearn T
    Atherosclerosis; 1976 Sep; 24(3):537-46. PubMed ID: 788722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological investigation of bezafibrate, a hypolipidemic agent (2). Mechanism of the hypolipidemic action of bezafibrate in rats].
    Kusama H; Nishiyama M; Matsubara Y; Ikeda S
    Nihon Yakurigaku Zasshi; 1988 Sep; 92(3):181-91. PubMed ID: 2907502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the hypolipidemic effect of fish oil by inhibition of adipose tissue lipolysis with acipimox, a nicotinic acid analog.
    Seböková E; Klimes I; Hermann M; Minchenko A; Mitková A; Hromadová M
    Ann N Y Acad Sci; 1993 Jun; 683():183-91. PubMed ID: 8102515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lipoproteins and cholesterol metabolism in Yoshida rats: an animal model of spontaneous hyperlipemia.
    Fantappiè S; Catapano AL; Cancellieri M; Fasoli L; De Fabiani E; Bertolini M; Bosisio E
    Life Sci; 1992; 50(24):1913-24. PubMed ID: 1598076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of 2-acetoamidoethyl (p-chloro-phenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on hepatic drug metabolism in retired breeder rats.
    Anthony LE; Jones AL
    Proc Soc Exp Biol Med; 1977 Jan; 154(1):142-5. PubMed ID: 402655
    [No Abstract]   [Full Text] [Related]  

  • 35. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
    Liang Y; She P; Wang X; Demarest K
    Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
    Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in rat serum lipids and apolipoproteins following clofibrate treatment.
    Dashti N; Ontko JA
    Atherosclerosis; 1983 Dec; 49(3):255-66. PubMed ID: 6419747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
    Allen T; Zhang F; Moodie SA; Clemens LE; Smith A; Gregoire F; Bell A; Muscat GE; Gustafson TA
    Diabetes; 2006 Sep; 55(9):2523-33. PubMed ID: 16936200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats.
    Russell JC; Dolphin PJ; Hameed M; Stewart B; Koeslag DG; Rose-Kahn G; Bar-Tana J
    Arterioscler Thromb; 1991; 11(3):602-9. PubMed ID: 2029500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.